Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Dr Gilles Divita
Founder and CEO at Divincell
Speaker

Profile

Dr. Gilles DIVITA is founder and CEO of DIVINCELL (FR) and CSO of AANATRA LLC, California (USA). BioPharmaceutical NanoMedicine Start-up pioneering a novel drug delivery technology for the treatment of cancer and genetic diseases. Dr. DIVITA has over 25 years of experience in drug delivery systems, peptide-drugs and oligonucleotide therapeutics. He is the pioneer of the “non covalent cell penetrating peptide-based strategy” for therapeutic delivery and inventor of the peptide-based platform for RNA therapeutic strategy.

Agenda Sessions

  • PEP-NP : Peptide Based Nanoparticle-platform for Targeted Delivery of Functional RNAs

    10:15